Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.79)
# 550
Out of 5,000 analysts
678
Total ratings
48.6%
Success rate
17.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine | Upgraded: Buy | $5 | $2.75 | +81.82% | 2 | Sep 23, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $106 → $86 | $61.35 | +40.18% | 9 | Sep 17, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $89 → $80 | $43.81 | +82.61% | 14 | Sep 14, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $40 → $44 | $32.99 | +33.37% | 4 | Sep 9, 2026 | |
| SCTX Scribe Therapeutics | Initiated Coverage: Buy | $50 | $21.61 | +131.37% | 1 | Aug 18, 2026 | |
| SPRB Spruce Biosciences | Reiterated: Buy | $123 → $104 | $49.02 | +112.16% | 2 | Aug 17, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $69 → $81 | $31.25 | +159.20% | 4 | Aug 11, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $43 → $35 | $14.77 | +136.97% | 6 | Aug 3, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $32.45 | $12.34 | +162.99% | 4 | Jul 9, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $51 | $41.16 | +23.91% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $11 | $3.94 | +179.19% | 5 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.64 | - | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.16 | - | 7 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.80 | - | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.68 | +161.19% | 4 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $17 | $6.22 | +173.31% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.87 | +228.54% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $2.80 | +685.71% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $6.33 | +200.16% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $22.74 | +97.89% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $344.96 | -17.67% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $7.48 | +247.59% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $26.21 | +121.29% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $3.39 | +784.96% | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $95 | $38.32 | n/a | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $18.39 | n/a | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $5 | $3.07 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 → $546 | $522.38 | n/a | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $55 | $24.66 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $16.51 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $55.70 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $249.59 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $24 | $4.79 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.1471 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $15.71 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.96 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $25.29 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | CHF 3.40 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $30.36 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $30 | $9.22 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $24.12 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.91 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $1.67 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.73 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $2.33 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $26.81 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $3.80 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $59.38 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $16.38 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $32.90 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $118.51 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $1.5 | $0.7405 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $19.56 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $63 | $62.28 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.2575 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $14.12 | n/a | 13 | Aug 14, 2015 |
Editas Medicine
Sep 23, 2026
Upgraded: Buy
Price Target: $5
Current: $2.75
Upside: +81.82%
BioMarin Pharmaceutical
Sep 17, 2026
Reiterated: Buy
Price Target: $106 → $86
Current: $61.35
Upside: +40.18%
Ionis Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $89 → $80
Current: $43.81
Upside: +82.61%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $32.99
Upside: +33.37%
Scribe Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $21.61
Upside: +131.37%
Spruce Biosciences
Aug 17, 2026
Reiterated: Buy
Price Target: $123 → $104
Current: $49.02
Upside: +112.16%
Neurogene
Aug 11, 2026
Reiterated: Buy
Price Target: $69 → $81
Current: $31.25
Upside: +159.20%
Ultragenyx Pharmaceutical
Aug 3, 2026
Reiterated: Buy
Price Target: $43 → $35
Current: $14.77
Upside: +136.97%
Satellos Bioscience Inc.
Jul 9, 2026
Reiterated: Buy
Price Target: $32.45
Current: $12.34
Upside: +162.99%
Edgewise Therapeutics
Jul 6, 2026
Reiterated: Buy
Price Target: $51
Current: $41.16
Upside: +23.91%
Jun 15, 2026
Rated: Buy
Price Target: $6 → $11
Current: $3.94
Upside: +179.19%
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $9.64
Upside: -
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $12.16
Upside: -
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.80
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.68
Upside: +161.19%
Jun 5, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $6.22
Upside: +173.31%
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.87
Upside: +228.54%
Jun 2, 2026
Reiterated: Buy
Price Target: $22
Current: $2.80
Upside: +685.71%
May 28, 2026
Reiterated: Buy
Price Target: $19
Current: $6.33
Upside: +200.16%
May 7, 2026
Reiterated: Buy
Price Target: $45
Current: $22.74
Upside: +97.89%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $344.96
Upside: -17.67%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $7.48
Upside: +247.59%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $26.21
Upside: +121.29%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $3.39
Upside: +784.96%
Sep 24, 2025
Reiterated: Buy
Price Target: $28 → $95
Current: $38.32
Upside: n/a
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $18.39
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $20 → $5
Current: $3.07
Upside: n/a
Aug 6, 2025
Reiterated: Buy
Price Target: $450 → $546
Current: $522.38
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $78 → $55
Current: $24.66
Upside: n/a
Aug 14, 2024
Reiterated: Buy
Price Target: $45 → $50
Current: $16.51
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $55.70
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $249.59
Upside: n/a
Apr 5, 2022
Reiterated: Buy
Price Target: $28 → $24
Current: $4.79
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.1471
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $15.71
Upside: n/a
Sep 1, 2020
Reiterated: Buy
Price Target: $20
Current: $3.96
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $25.29
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: CHF 3.40
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $30.36
Upside: n/a
Aug 11, 2020
Reiterated: Buy
Price Target: $36 → $30
Current: $9.22
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $24.12
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $1.91
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $1.67
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $3.73
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $2.33
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $54
Current: $26.81
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $3.80
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $59.38
Upside: n/a
Dec 18, 2019
Reiterated: Buy
Price Target: $2
Current: $16.38
Upside: n/a
Aug 1, 2017
Reiterated: Hold
Price Target: n/a
Current: $32.90
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $118.51
Upside: n/a
Oct 20, 2016
Reiterated: Hold
Price Target: $9 → $1.5
Current: $0.7405
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $19.56
Upside: n/a
Oct 16, 2015
Reiterated: Hold
Price Target: $63
Current: $62.28
Upside: n/a
Aug 16, 2015
Reiterated: Buy
Price Target: $4
Current: $0.2575
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $14.12
Upside: n/a